Atrial Fibrillation Also called: AF, Afib

Clinical Trial Finder

Many patients with atrial fibrillation are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Impaired Left Ventricular Function

Conditions:   Persistent Atrial Fibrillation;   Congestive Heart Failure Due to Left Ventricular Systolic Dysfunction
Interventions:   Procedure: Atrial fibrillation catheter ablation;   Procedure: Rate control
Sponsors:   University of Turin, Italy;   Centro Cardiologico Monzino;   Humanitas Research Hospital IRCCS, Rozzano-Milan;   University of Padua;   Policlinico Casilino ASL RMB
Not yet recruiting - verified July 2015

Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation

Condition:   Paroxysmal Atrial Fibrillation
Intervention:   Drug: rosuvastatin
Sponsor:   The Third Xiangya Hospital of Central South University
Not yet recruiting - verified July 2015

mHealth Screening to Prevent Strokes

Condition:   Atrial Fibrillation
Interventions:   Device: iRhythm ZIO XT Patch;   Device: Wristband by Amiigo
Sponsors:   Scripps Translational Science Institute;   Janssen Scientific Affairs, LLC;   Aetna, Inc.
Not yet recruiting - verified July 2015

ELR Monitoring Against Permanent Pacemaker in Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Device: R test;   Device: Nuubo;   Device: TECHNOMED pocket ECG;   Device: ZIO xt patch;   Device: MoMe
Sponsor:   Eastbourne General Hospital
Not yet recruiting - verified July 2015

Laser Ablation Study for trEatment of atRial Fibrillation (LASER)

Condition:   Atrial Fibrillation
Interventions:   Device: Laser ablation;   Device: RF ablation
Sponsors:   Hospital Clinic of Barcelona;   CardioFocus
Recruiting - verified July 2015

Mobile Phones in Cryptogenic Stroke Patients Bringing Single Lead ECGs to Detect Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Ischemic Stroke;   Transient Ischemic Attack
Interventions:   Device: Single lead ECG device;   Device: 7-Day Holter monitor.
Sponsors:   Leiden University Medical Center;   Medical Center Haaglanden;   Groene Hart Ziekenhuis;   Herning Hospital;   Bronovo Hospital
Not yet recruiting - verified July 2015

Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

Conditions:   Cancer;   Deep-vein Thrombosis of the Lower and Upper Extremities;   Pulmonary Embolism;   Non-valvular Atrial Fibrillation
Intervention:   Other: Retrospective Chart Review
Sponsors:   M.D. Anderson Cancer Center;   Janssen Scientific Affairs, LLC
Not yet recruiting - verified July 2015

Prospective Record Of the Use of Dabigatran in Patients With Acute Stroke or TIA

Conditions:   Brain Ischemia With Non-valvular Atrial Fibrillation;   Transient Ischemic Attack With Non-valvular Atrial Fibrillation
Intervention:  
Sponsor:   University Hospital, Essen
Recruiting - verified July 2015

Clinical Trial for Optimal Novel Oral Anticoagulant (NOAC) Schedule Immediate Before Catheter Ablation for Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Drug: novel oral anticoagulant for 30 days;   Drug: novel oral anticoagulant for 24 hour
Sponsor:   Yonsei University
Recruiting - verified July 2015

A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care

Conditions:   Pain;   Chronic Pain;   Mental Disorders;   Cardiovascular Diseases;   Diabetes Mellitus, Type 2;   Arthritis
Interventions:   Other: Unblinded to Genetic Testing Results;   Other: Blinded to Genetic Testing Results
Sponsor:   Proove Bioscience, Inc.
Recruiting - verified July 2015

WATCHMAN Implantation During Hybrid Ablation

Conditions:   Atrial Fibrillation;   Stroke
Intervention:   Device: WATCHMAN Device implantation
Sponsors:   Maastricht University Medical Center;   Boston Scientific Corporation
Recruiting - verified July 2015

Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study)

Condition:   Anticoagulation, Blood Thinners , Atrial Fibrillation, Bleeding, Stroke
Intervention:  
Sponsor:   Bristol-Myers Squibb
Recruiting - verified July 2015

Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry)

Condition:   Atrial Fibrillation
Intervention:  
Sponsors:   Medtronic Atrial Fibrillation Solutions;   IHF GmbH - Institut für Herzinfarktforschung
Recruiting - verified July 2015

Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)

Condition:   Atrial Fibrillation
Interventions:   Drug: Warfarin;   Drug: Dabigatran Etexilate 150mg
Sponsor:   Boehringer Ingelheim
Recruiting - verified July 2015

Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter

Conditions:   Atrial Fibrillation;   Stroke
Intervention:   Other: Computer Electronic Alert
Sponsors:   Brigham and Women's Hospital;   Daiichi Sankyo Inc.
Not yet recruiting - verified July 2015

Canadian Community Utilization of Stroke Prevention Study - Emergency Department

Conditions:   Atrial Fibrillation;   Stroke
Interventions:   Other: Retrospective review of OAC prescription;   Other: Prescription of OAC in ED;   Other: Community AF clinic
Sponsor:   Population Health Research Institute
Recruiting - verified July 2015

CCC Project - Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:  
Sponsors:   Beijing Institute of Heart, Lung and Blood Vessel Diseases;   American Heart Association;   Chinese Society of Cardiology
Recruiting - verified July 2015

FAST Mapping During Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Procedure: FAST mapping and ablation;   Procedure: PVI
Sponsor:   University Health Network, Toronto
Recruiting - verified July 2015

Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study

Condition:   Stroke, Acute
Intervention:  
Sponsors:   University of Zurich;   Swiss National Science Foundation
Recruiting - verified July 2015

Program for the Identification of "Actionable" Atrial Fibrillation in the Family Practice Setting

Condition:   Atrial Fibrillation
Interventions:   Other: 30 Second Pulse Check;   Device: Watch BP Home A;   Device: HeartCheck Hand-held ECG device
Sponsors:   Population Health Research Institute;   Canadian Institutes of Health Research  (CIHR)
Recruiting - verified July 2015

Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)

Condition:   Atrial Fibrillation
Interventions:   Drug: Dabigatran etexilate;   Drug: Phenprocoumon
Sponsor:   Boehringer Ingelheim
Recruiting - verified July 2015

Cologne Cardioversion Study

Conditions:   Atrial Arrhythmia;   Heart Failure
Interventions:   Device: Internal Electrocardioversion;   Device: External Electrocardioversion
Sponsors:   Universitätsklinikum Köln ;   Medtronic;   St. Jude Medical
Recruiting - verified July 2015

Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants

Conditions:   Venous Thromboembolism;   Atrial Fibrillation
Intervention:   Other: complications and compliance with GIHP recommendations
Sponsors:   University Hospital, Grenoble;   Floralis
Recruiting - verified July 2015

Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)

Conditions:   Atrial Fibrillation;   Percutaneous Coronary Intervention
Interventions:   Drug: Dabigatran Etexilate 110mg;   Drug: Warfarin 3mg;   Drug: Aspirin;   Drug: Dabigatran Etexilate 150mg;   Drug: Clopidogrel or Ticagrelor;   Drug: Clopidogrel or Ticagrelor;   Drug: Warfarin 5mg;   Drug: Clopidogrel or Ticagrelor;   Drug: Warfarin 1mg
Sponsor:   Boehringer Ingelheim
Recruiting - verified July 2015

Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers

Condition:   Atrial Fibrillation
Interventions:   Drug: BMS-919373;   Drug: Sotalol;   Drug: Placebo for BMS-919373
Sponsor:   Bristol-Myers Squibb
Recruiting - verified July 2015

A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation

Condition:   Paroxysmal Atrial Fibrillation
Interventions:   Drug: BMS-919373;   Drug: Placebo (Matching with BMS-919373)
Sponsor:   Bristol-Myers Squibb
Recruiting - verified April 2015

Atrial Fibrillation, Cardiac Symptoms, and Anxiety

Conditions:   Atrial Fibrillation;   Anxiety
Intervention:   Behavioral: Mindfulness and Interoceptive Exposure
Sponsor:   Brigham and Women's Hospital
Recruiting - verified July 2015

Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure

Condition:   Permanent Atrial Fibrillation
Interventions:   Procedure: AV junction ablation;   Device: CRT;   Drug: Optimized drug therapy;   Device: ICD
Sponsor:   Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella
Recruiting - verified July 2015

Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation

Condition:   Atrial Fibrillation
Interventions:   Drug: edoxaban;   Drug: Enoxaparin;   Drug: Warfarin
Sponsors:   Daiichi Sankyo Inc.;   Covance;   Quintiles
Recruiting - verified July 2015

Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)

Condition:   Atrial Fibrillation
Interventions:   Drug: Apixaban;   Drug: Parenteral heparin and/or oral Vitamin K antagonist
Sponsors:   Pfizer;   Bristol-Myers Squibb
Recruiting - verified July 2015

Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)

Conditions:   Ischemic Stroke;   Atrial Fibrillation;   Transient Ischemic Attacks;   Transient Cerebrovascular Events
Intervention:   Other: Biomarker blood draw
Sponsor:   Ischemia Care LLC
Recruiting - verified July 2015

Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients With Heart Failure and Preserved Ejection Fraction

Condition:   Heart Failure With Preserved Ejection Fraction (HFpEF)
Intervention:   Device: ILR implantation
Sponsors:   University Medical Centre Groningen;   St. Jude Medical
Recruiting - verified July 2015

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Conditions:   Rivaroxaban;   Cancer-associated Thrombosis;   Recurrence;   Bleeding
Intervention:   Drug: Rivaroxaban
Sponsors:   Seoul National University Hospital;   Korean Society of Hematology Thrombosis Working Party
Recruiting - verified July 2015

Pacing in First-degree AV-block

Conditions:   First-degree AV-block;   Pacing
Intervention:   Other: Pacing
Sponsors:   Duke University;   Medtronic
Not yet recruiting - verified February 2015

Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN)

Condition:   Non-valvular Atrial Fibrillation
Intervention:   Drug: Apixaban
Sponsor:   Bristol-Myers Squibb
Recruiting - verified December 2014

Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery

Conditions:   Vascular Death;   Myocardial Infarction;   Stroke;   Cardiac Surgery
Intervention:  
Sponsors:   Population Health Research Institute;   Abbott Diagnostics Division
Recruiting - verified July 2015

A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention

Conditions:   Atrial Fibrillation;   Percutaneous Coronary Intervention
Interventions:   Drug: rivaroxaban 2.5 mg;   Drug: rivaroxaban 15 mg;   Drug: rivaroxaban 10 mg;   Drug: aspirin (ASA);   Drug: vitamin K antagonist (VKA);   Drug: clopidogrel;   Drug: prasugrel;   Drug: ticagrelor
Sponsors:   Janssen Scientific Affairs, LLC;   Bayer
Recruiting - verified July 2015

SPARK: Safety Study of Pradaxa in Atrial Fibrillation Patients by Regulatory Requirement of Korea

Condition:   Atrial Fibrillation
Intervention:   Drug: Pradaxa (Dabigatran etexilate mesilate)
Sponsor:   Boehringer Ingelheim
Recruiting - verified July 2015

Validation Durability Adenosine Effect in Verification Pulmonary Vein Isolation

Condition:   Atrial Fibrillation
Intervention:   Drug: Adenosine arm
Sponsor:   Medical College of Wisconsin
Completed - verified July 2015

Risk Profile for Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   University Medical Centre Groningen
Completed - verified July 2015

Risk Profile for Patients With Atrial Fibrillation

Condition:   Atrial Fibrillation
Intervention:  
Sponsors:   I.C. Van Gelder;   Netherlands Heart Foundation
Recruiting - verified July 2015

Markers of Paroxysmal Atrial Fibrillation in Esophageal Holter Electrocardiography

Conditions:   Atrial Fibrillation;   Atrial Premature Complexes
Intervention:  
Sponsors:   University Hospital Inselspital, Berne;   Commission for Technology and Innovation of the Swiss Federal Administration
Completed - verified July 2015

Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery

Condition:   Atrial Fibrillation
Interventions:   Drug: Amiodarone;   Drug: Minocycline
Sponsor:   Baystate Medical Center
Active, not recruiting - verified July 2015

Minimally Invasive Surgical Treatment Versus Medical Management for Stroke Patients With Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Stroke
Interventions:   Procedure: Minimally Invasive Surgery;   Other: Medical therapy
Sponsor:   University of Florida
Completed - verified July 2015

Routine Versus Aggressive Upstream Rhythm Control for Prevention of Early Atrial Fibrillation in Heart Failure

Condition:   Atrial Fibrillation
Interventions:   Other: Upstream therapy;   Other: Conventional rhythm control
Sponsors:   I.C. Van Gelder;   The Interuniversity Cardiology Institute of the Netherlands;   Netherlands Heart Foundation;   Dutch Network for Cardiovascular Research;   Trial Coordination Center UMC Groningen;   Bayer;   Boehringer Ingelheim;   Medtronic;   Biotronik SE & Co. KG;   St. Jude Medical;   Boston Scientific Corporation;   AstraZeneca
Recruiting - verified July 2015

Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter

Conditions:   Atrial Fibrillation;   Atrial Flutter
Interventions:   Drug: Ramipril;   Drug: Placebo
Sponsors:   Centre Hospitalier Universitaire de Saint Etienne;   Sanofi;   Ministry of Health, France;   Sorin Group
Terminated - verified July 2015

Get CardioSmart

You're Invited

CardioSmart Points

Log in to Check Your Balance
and Go Shopping

Learn how to earn more CardioSmart Points